Company Overview

Update
Headquarters:
Sydney
IPO:
Went Public on Mar 9, 2009
Stock:
ASX:VLA
Categories:
Biotechnology

Viralytics is an Australian biotechnology company, listed on the Australian Stock Exchange (ASX:VLA) and is quoted on the OTC market

Description

Update

Viralytics is an Australian biotechnology company, listed on the Australian Stock Exchange (ASX:VLA) and is quoted on the OTC market (VRACY). Focused on developing oncolytic virotherapy for the treatment of a wide range of cancers Viralytics' headquarters are in Sydney, Australia and research and operations are in Newcastle, Australia.

Oncolytic virotherapy makes use of the cancer destroying capabilities of a range of benign viruses. The potential of oncolytic virotherapy is the ability to treat cancers more effectively and with minimum side-effects.

Funding Rounds (1) - $27M

Update

Offices/Locations (1)

Update
  • Office

    Suite 305, Level 3

    66 Hunter Street, New South Wales,

    Sydney, 2000

    AUS

Images (1)

Update
  • A8bea4a1ffe69f7a4bbe4a17a52aba5a